Revascularization and survival in multivessel coronary artery disease in ischemia is a research paper published in JTCVS Open (2022). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 11UL1 TR001445
National Institutes of Health
Grant: U01HL105462
National Institutes of Health
Grant: U01HL105561
National Institutes of Health
Grant: U01HL105565
National Institutes of Health
Grant: UL1 TR002243
NHLBI
Grant: U01HL105907
NCATS NIH HHS
Grant: UL1 TR001445
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 3UL1TR001445-03S1
Clinical and Translational Science Award
National Institutes of Health
Grant: 4U01HL105462-05
The ISCHEMIA Trial - SDCC
National Institutes of Health
Grant: 3U01HL105907-02S1
The Ischemia Trial - CCC
National Institutes of Health
Grant: 4U01HL105561-05
The ISCHEMIA Trial - IICC
National Institutes of Health
Grant: 5U01HL105565-03
The ISCHEMIA Trial - EQOL
Sunovion
National Center for Advancing Translational Sciences
Amgen
Merck Sharp and Dohme
AstraZeneca
FWCI
0.21
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals